New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global

BioVie CEO Cuong Do discussed the company’s recent Long COVID clinical results and the potential for bezisterim to address unmet patient needs. The provided text contains no clinical efficacy, safety, financial, regulatory, or commercial data to assess the magnitude of the results or likely valuation impact.